HEADER TRANSFERASE 25-OCT-05 2ERZ TITLE CRYSTAL STRUCTURE OF C-AMP DEPENDENT KINASE (PKA) BOUND TO TITLE 2 HYDROXYFASUDIL COMPND MOL_ID: 1; COMPND 2 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE, ALPHA-CATALYTIC SUBUNIT; COMPND 3 CHAIN: E; COMPND 4 SYNONYM: PKA C-ALPHA; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CAMP-DEPENDENT PROTEIN KINASE INHIBITOR, ALPHA FORM; COMPND 9 CHAIN: I; COMPND 10 FRAGMENT: RESIDUES 5-24; COMPND 11 SYNONYM: PKI-ALPHA, CAMP- DEPENDENT PROTEIN KINASE INHIBITOR, COMPND 12 MUSCLE/BRAIN ISOFORM; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PRKACA, PKACA; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 OTHER_DETAILS: THIS SEQUENCE OCCURS NATURALLY IN ORYCTOLAGUS SOURCE 11 CUNICULUS (RABBIT) KEYWDS FASUDIL KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.JACOBS REVDAT 4 23-AUG-23 2ERZ 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 2ERZ 1 VERSN REVDAT 2 24-JAN-06 2ERZ 1 JRNL AUTHOR REVDAT 1 08-NOV-05 2ERZ 0 JRNL AUTH M.JACOBS,K.HAYAKAWA,L.SWENSON,S.BELLON,M.FLEMING,P.TASLIMI, JRNL AUTH 2 J.DORAN JRNL TITL THE STRUCTURE OF DIMERIC ROCK I REVEALS THE MECHANISM FOR JRNL TITL 2 LIGAND SELECTIVITY. JRNL REF J.BIOL.CHEM. V. 281 260 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16249185 JRNL DOI 10.1074/JBC.M508847200 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.80 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 139000.516 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 22170 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.227 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.287 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1525 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 23695 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.34 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.90 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3047 REMARK 3 BIN R VALUE (WORKING SET) : 0.3360 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 7.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 229 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2934 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 21 REMARK 3 SOLVENT ATOMS : 61 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.49000 REMARK 3 B22 (A**2) : 3.48000 REMARK 3 B33 (A**2) : -5.97000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.29 REMARK 3 ESD FROM SIGMAA (A) : 0.36 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.38 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.700 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.670 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.000 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 5.720 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 7.320 ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.33 REMARK 3 BSOL : 44.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN.TOP REMARK 3 PARAMETER FILE 2 : INHIB.RTF REMARK 3 PARAMETER FILE 3 : MASS1.DAT REMARK 3 PARAMETER FILE 4 : WATER.TOP REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN_REP.PARAM REMARK 3 TOPOLOGY FILE 2 : WATER_REP.PARAM REMARK 3 TOPOLOGY FILE 3 : MISSING.DAT REMARK 3 TOPOLOGY FILE 4 : PARMXRAY.XPL REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2ERZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-OCT-05. REMARK 100 THE DEPOSITION ID IS D_1000035019. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-04 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22293 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 27.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 200 DATA REDUNDANCY : 4.870 REMARK 200 R MERGE (I) : 0.07500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.34400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1ATP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.67 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: BICINE, PH 7.0, 2% MPD, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.39700 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.02400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.87550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 40.02400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.39700 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.87550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL ASSEMBLY IS SAME AS ASYM. UNIT: ONE PROTEIN REMARK 300 MOLECULE (PKA), ONE INHIBITOR PEPTIDE (PKI), ONE LIGAND REMARK 300 (HYDROXYFASUDIL) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2720 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15900 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET E 0 REMARK 465 GLY E 1 REMARK 465 ASN E 2 REMARK 465 ALA E 3 REMARK 465 ALA E 4 REMARK 465 ALA E 5 REMARK 465 ALA E 6 REMARK 465 LYS E 7 REMARK 465 LYS E 8 REMARK 465 GLY E 9 REMARK 465 SER E 10 REMARK 465 GLU E 11 REMARK 465 GLN E 12 REMARK 465 GLU E 13 REMARK 465 SER E 14 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH I 31 O HOH I 35 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN E 99 101.48 -164.64 REMARK 500 ASP E 166 40.60 -148.03 REMARK 500 ASP E 184 90.43 70.07 REMARK 500 LEU E 273 45.60 -79.95 REMARK 500 LYS E 319 29.11 -77.39 REMARK 500 SEP E 338 157.19 -48.11 REMARK 500 HIS I 23 -81.00 -90.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HFS E 351 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2ESM RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ROCK 1 BOUND TO FASUDIL REMARK 900 RELATED ID: 2ETR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ROCK I BOUND TO Y-27632 REMARK 900 RELATED ID: 2ETO RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ROCK I BOUND TO H-1152P-A DI-METHYLATED REMARK 900 VARIANT OF FASUDIL REMARK 900 RELATED ID: 2ETK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF ROCK 1 BOUND TO HYDROXYFASUDIL DBREF 2ERZ E 0 350 UNP P05132 KAPCA_MOUSE 0 350 DBREF 2ERZ I 5 24 UNP P61926 IPKA_RABIT 5 24 SEQADV 2ERZ TPO E 197 UNP P05132 THR 197 MODIFIED RESIDUE SEQADV 2ERZ SEP E 338 UNP P05132 SER 338 MODIFIED RESIDUE SEQRES 1 E 351 MET GLY ASN ALA ALA ALA ALA LYS LYS GLY SER GLU GLN SEQRES 2 E 351 GLU SER VAL LYS GLU PHE LEU ALA LYS ALA LYS GLU ASP SEQRES 3 E 351 PHE LEU LYS LYS TRP GLU THR PRO SER GLN ASN THR ALA SEQRES 4 E 351 GLN LEU ASP GLN PHE ASP ARG ILE LYS THR LEU GLY THR SEQRES 5 E 351 GLY SER PHE GLY ARG VAL MET LEU VAL LYS HIS LYS GLU SEQRES 6 E 351 SER GLY ASN HIS TYR ALA MET LYS ILE LEU ASP LYS GLN SEQRES 7 E 351 LYS VAL VAL LYS LEU LYS GLN ILE GLU HIS THR LEU ASN SEQRES 8 E 351 GLU LYS ARG ILE LEU GLN ALA VAL ASN PHE PRO PHE LEU SEQRES 9 E 351 VAL LYS LEU GLU PHE SER PHE LYS ASP ASN SER ASN LEU SEQRES 10 E 351 TYR MET VAL MET GLU TYR VAL ALA GLY GLY GLU MET PHE SEQRES 11 E 351 SER HIS LEU ARG ARG ILE GLY ARG PHE SER GLU PRO HIS SEQRES 12 E 351 ALA ARG PHE TYR ALA ALA GLN ILE VAL LEU THR PHE GLU SEQRES 13 E 351 TYR LEU HIS SER LEU ASP LEU ILE TYR ARG ASP LEU LYS SEQRES 14 E 351 PRO GLU ASN LEU LEU ILE ASP GLN GLN GLY TYR ILE GLN SEQRES 15 E 351 VAL THR ASP PHE GLY PHE ALA LYS ARG VAL LYS GLY ARG SEQRES 16 E 351 THR TRP TPO LEU CYS GLY THR PRO GLU TYR LEU ALA PRO SEQRES 17 E 351 GLU ILE ILE LEU SER LYS GLY TYR ASN LYS ALA VAL ASP SEQRES 18 E 351 TRP TRP ALA LEU GLY VAL LEU ILE TYR GLU MET ALA ALA SEQRES 19 E 351 GLY TYR PRO PRO PHE PHE ALA ASP GLN PRO ILE GLN ILE SEQRES 20 E 351 TYR GLU LYS ILE VAL SER GLY LYS VAL ARG PHE PRO SER SEQRES 21 E 351 HIS PHE SER SER ASP LEU LYS ASP LEU LEU ARG ASN LEU SEQRES 22 E 351 LEU GLN VAL ASP LEU THR LYS ARG PHE GLY ASN LEU LYS SEQRES 23 E 351 ASN GLY VAL ASN ASP ILE LYS ASN HIS LYS TRP PHE ALA SEQRES 24 E 351 THR THR ASP TRP ILE ALA ILE TYR GLN ARG LYS VAL GLU SEQRES 25 E 351 ALA PRO PHE ILE PRO LYS PHE LYS GLY PRO GLY ASP THR SEQRES 26 E 351 SER ASN PHE ASP ASP TYR GLU GLU GLU GLU ILE ARG VAL SEQRES 27 E 351 SEP ILE ASN GLU LYS CYS GLY LYS GLU PHE THR GLU PHE SEQRES 1 I 20 THR THR TYR ALA ASP PHE ILE ALA SER GLY ARG THR GLY SEQRES 2 I 20 ARG ARG ASN ALA ILE HIS ASP MODRES 2ERZ TPO E 197 THR PHOSPHOTHREONINE MODRES 2ERZ SEP E 338 SER PHOSPHOSERINE HET TPO E 197 11 HET SEP E 338 10 HET HFS E 351 21 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM HFS 1-(1-HYDROXY-5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE HETSYN HFS HYDROXYFASUDIL FORMUL 1 TPO C4 H10 N O6 P FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 HFS C14 H17 N3 O3 S FORMUL 4 HOH *61(H2 O) HELIX 1 1 VAL E 15 THR E 32 1 18 HELIX 2 2 GLN E 39 ASP E 41 5 3 HELIX 3 3 LYS E 76 LEU E 82 1 7 HELIX 4 4 GLN E 84 GLN E 96 1 13 HELIX 5 5 GLU E 127 GLY E 136 1 10 HELIX 6 6 SER E 139 LEU E 160 1 22 HELIX 7 7 LYS E 168 GLU E 170 5 3 HELIX 8 8 THR E 201 LEU E 205 5 5 HELIX 9 9 ALA E 206 LEU E 211 1 6 HELIX 10 10 LYS E 217 GLY E 234 1 18 HELIX 11 11 GLN E 242 SER E 252 1 11 HELIX 12 12 SER E 262 LEU E 273 1 12 HELIX 13 13 ASP E 276 ARG E 280 5 5 HELIX 14 14 VAL E 288 ASN E 293 1 6 HELIX 15 15 HIS E 294 ALA E 298 5 5 HELIX 16 16 ASP E 301 GLN E 307 1 7 HELIX 17 17 GLY E 344 THR E 348 5 5 HELIX 18 18 THR I 5 SER I 13 1 9 SHEET 1 A 5 PHE E 43 THR E 51 0 SHEET 2 A 5 ARG E 56 HIS E 62 -1 O LEU E 59 N LYS E 47 SHEET 3 A 5 ASN E 67 ASP E 75 -1 O ASN E 67 N HIS E 62 SHEET 4 A 5 ASN E 115 GLU E 121 -1 O MET E 120 N ALA E 70 SHEET 5 A 5 LEU E 106 LYS E 111 -1 N PHE E 110 O TYR E 117 SHEET 1 B 2 LEU E 162 ILE E 163 0 SHEET 2 B 2 LYS E 189 ARG E 190 -1 O LYS E 189 N ILE E 163 SHEET 1 C 2 LEU E 172 ILE E 174 0 SHEET 2 C 2 ILE E 180 VAL E 182 -1 O GLN E 181 N LEU E 173 LINK C TRP E 196 N TPO E 197 1555 1555 1.33 LINK C TPO E 197 N LEU E 198 1555 1555 1.33 LINK C VAL E 337 N SEP E 338 1555 1555 1.33 LINK C SEP E 338 N ILE E 339 1555 1555 1.33 SITE 1 AC1 12 THR E 51 VAL E 57 ALA E 70 GLU E 121 SITE 2 AC1 12 TYR E 122 VAL E 123 ASN E 171 LEU E 173 SITE 3 AC1 12 THR E 183 ASP E 184 PHE E 327 ARG I 18 CRYST1 72.794 75.751 80.048 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013737 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013201 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012493 0.00000